NOTES PAYABLE (Details Narrative) - USD ($) |
9 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Feb. 13, 2025 |
Jan. 22, 2025 |
Dec. 31, 2024 |
Dec. 30, 2024 |
Oct. 02, 2024 |
Sep. 27, 2024 |
Sep. 30, 2025 |
Sep. 30, 2024 |
|
| Debt interest rate | 20.00% | 20.00% | 20.00% | 20.00% | 20.00% | 20.00% | ||
| Principal amount | $ 31,250 | $ 31,250 | $ 279,878 | $ 40,625 | $ 62,500 | $ 1,066,391 | $ 9,687,500 | |
| Gross proceeds | $ 2,500,000 | $ 2,500,000 | $ 2,500,000 | $ 2,500,000 | $ 2,500,000 | $ 2,500,000 | $ 257,645 | |
| Debt interest stated percentage | 5.00% | 5.00% | 5.00% | 5.00% | 5.00% | 5.00% | ||
| Debt unamortized discount | $ 6,250 | $ 6,250 | $ 46,646 | $ 8,125 | $ 12,500 | $ 213,278 | $ 5,943,425 | |
| Aspire Biopharma Inc [Member] | ||||||||
| Debt interest rate | 20.00% | 20.00% | 20.00% | 20.00% | ||||
| Principal amount | $ 279,878 | $ 40,625 | $ 62,500 | $ 1,066,391 | ||||
| Gross proceeds | $ 2,500,000 | $ 2,500,000 | $ 2,500,000 | $ 2,500,000 | ||||
| Debt interest stated percentage | 5.00% | 5.00% | 5.00% | 5.00% | ||||
| Debt unamortized discount | $ 46,646 | $ 8,125 | $ 12,500 | $ 213,278 | ||||